News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
141 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook
Fourth-quarter GAAP earnings were $0.85 per share, a decrease of 55 percent versus the fourth quarter of 2016.
January 25, 2018
·
25 min read
Business
Novartis Buys Access to Spark’s Landmark Gene Therapy Drug With $170M Deal
Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65.
January 25, 2018
·
11 min read
Business
Sobi Names Holly May Vice President of Sales and Marketing in United States
May will lead the commercial team in bringing Sobi’s multiple approved medicines to patients in the U.S.
January 25, 2018
·
3 min read
Pharm Country
Advaxis’ Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in International Journal of Radiation Oncology
Advaxis today announces that data from the investigator-initiated study evaluating the Company’s proprietary Lm-based antigen delivery product.
January 25, 2018
·
4 min read
Biotech Bay
Tangible Science Expands into Disposable Contact Lenses Incorporating Polymer Technology Behind Tangible Hydra-PEG
Tangible Science today announced it has expanded its product family to include disposable contact lenses.
January 25, 2018
·
1 min read
Business
Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018
Following the conclusion of the conference call, a replay will be available through February 8, 2018.
January 25, 2018
·
1 min read
Biotech Beach
GW Pharma and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex (cannabidiol) Study in The Lancet
GW Pharma along with its U.S. subsidiary Greenwich Biosciences, announced today that The Lancet has published results from a Phase 3 study of Epidiolex in patients with Lennox-Gastaut syndrome.
January 25, 2018
·
11 min read
Ergomed 2017 Trading Update
ErgoMed provides a trading update for the year ended 31 December 2017.
January 25, 2018
·
1 min read
Deals
Selcia Joins Eurofins Group
Selcia announces that it has been acquired by Eurofins Scientific.
January 25, 2018
·
1 min read
TSO3, Inc. Provides an Operational Update
TSO3 today provided an update on its 2017 operating activities.
January 25, 2018
·
5 min read
Previous
3 of 15
Next